Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.81), $0.11 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $66.9 million versus the consensus estimate of $63.35 million.

GUIDANCE:

Twist Bioscience Corporation sees Q1 2024 revenue of $67-68 million, versus the consensus of $62.97 million.

Twist Bioscience Corporation sees FY2024 revenue of $285-290 million, versus the consensus of $241.5 million.

Twist Bioscience Corporation sees Q4 2024 revenue of ~$78 million, versus the consensus of $78.44 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.